Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

GT Biopharma Inc (GTBP)

GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

GT Biopharma Inc 505 Montgomery Street 10th Floor San Francisco CA 94111 USA

www.gtbiopharma.com Employees: 1 P: 800-304-9888

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

GT Biopharma Inc. is an immuno-oncology company. It discovers, develops and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions and other unmet medical needs. GT Biopharma Inc., formerly known as OXIS International Inc., is based in Tampa, Florida.

Key Statistics

Overview:

Market Capitalization, $K 6,467
Enterprise Value, $K 2,427
Shares Outstanding, K 10,636
Annual Sales, $ 0 K
Annual Net Income, $ -13,160 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,110 K
EBIT, $ -10,580 K
EBITDA, $ -10,580 K
60-Month Beta 1.52
% of Insider Shareholders 3.40%
% of Institutional Shareholders 8.15%
Float, K 10,274
% Float 96.60%
Short Volume Ratio 0.58

Growth:

1-Year Return -77.01%
3-Year Return -98.63%
5-Year Return -99.54%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.97%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.83 on 11/14/25
Next Earnings Date 11/13/25
Earnings Per Share ttm -3.80
EPS Growth vs. Prev Qtr -50.91%
EPS Growth vs. Prev Year 45.75%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 02/05/24

GTBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,258.75%
Return-on-Assets % -220.17%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.53
Book Value/Share 0.50
Interest Coverage -0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar